ArticleBritish journal of clinical pharmacology2018
Patient involvement is essential in identifying drug-related problems.
Article in British journal of clinical pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Evaluation of clinical pharmacy services in patients receiving antithrombotic treatment in a randomized controlled trial.Scientific reports · 2025Trial
- Cost-effectiveness of a clinical medication review in vulnerable older patients at hospital discharge, a randomized controlled trial.International journal of clinical pharmacy · 2019Trial
- Characterising pharmacist interventions from person-centred medicines reviews in general practice settings.Exploratory research in clinical and social pharmacy · 2026Article
- Exploring the effect of training community pharmacy staff in mentalization-based communication on recognizing patients' drug related problems: an uncontrolled pre-post intervention study in Denmark and the Netherlands.Exploratory research in clinical and social pharmacy · 2026Article
- Text Messaging Between Patients With Inflammatory Rheumatic Diseases and Pharmacists to Solve Drug-Related Problems: Prospective Feasibility Study.JMIR human factors · 2025Article
- Factors Influencing the Intentions of Patients With Inflammatory Rheumatic Diseases to Use a Digital Human for Medication Information: Qualitative Study.Journal of medical Internet research · 2025Article
- Intervention description of pharmacist-facilitated medication reviews in Nordic primary care settings: a scoping review.Scandinavian journal of primary health care · 2025Article
- University Pharmacy Clinic: Preventing Errors and Enhancing Lives Through Expert Medication Management.Pharmacy (Basel, Switzerland) · 2025Article
- What should patients learn? Co-designing patient education to improve medication safety, professional-patient communication, and partnership.Frontiers in medicine · 2025Article
- Non-dispensed prescriptions - A nationwide descriptive study.Exploratory research in clinical and social pharmacy · 2024Article
- A newly developed algorithm for switching outpatient medications to medications listed in the hospital formulary: a prospective real-word evaluation in patients admitted electively to hospital.European journal of clinical pharmacology · 2024Article
- Drug-Related Problems Detected in Complex Chronic Patients by Community Pharmacists of Catalonia: Perception of the Person-Centred Approach Necessity.Healthcare (Basel, Switzerland) · 2024Article
- Implementation of pharmacotherapy monitoring: Experiences and views of medicine users.Exploratory research in clinical and social pharmacy · 2023Article
- Patient experiences and opinions on medication review: a qualitative study.International journal of clinical pharmacy · 2023Article
- Drug-related problems reported by patients with rheumatic diseases: an observational study.BMC rheumatology · 2023Article
- Pharmacist-Led Interventions to Reduce Drug-Related Problems in Prescribing for Pediatric Outpatients in a Developing Country: A Randomized Controlled Trial.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2023Article
- Article
- Conceptualization and content validation of the MEDication literacy assessment of geriatric patients and informal caregivers (MED-fLAG).Journal of patient-reported outcomes · 2022Article
- Developing an interprofessional people-centred care model for home-living older people with multimorbidities in a primary care health centre: A community-based study.Exploratory research in clinical and social pharmacy · 2022Article
- Prevalence and predictors of medication-related emergency department visit in older adults: A multicenter study linking national claim database and hospital medical records.Frontiers in pharmacology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsThe aim of this study is to evaluate how critical patient involvement is in pharmacist-led clinical medication reviews and in identifying the most significant clinical drug-related problems (DRPs).
methodsPharmacist-led clinical medication reviews were conducted with 161 consenting patients aged ≥75 years with at least seven prescribed medicines, living independently at home in Finland. A pharmacist, a nurse and a physician evaluated the clinical significance of the DRPs identified during the patient interview at an interprofessional case conference. It was evaluated whether the most significant clinical DRPs could also have been identified through reviewing the medication list only or the medication list and certain patient details.
resultsAltogether, the 111 most significant clinical DRPs were evaluated. Only 6% could have been identified through reviewing the medication list only, and 16% through reviewing the medication list and certain patient details. Hence, 84% of the most significant clinical DRPs could only have been identified with patient involvement. The most common DRPs were: poor therapy control (25%); nonoptimal drug (22%); intentional nonadherence (12%); and additional drug needed (11%). patient involvement was critical when identifying DRPs related to additional drug needed, unintentional nonadherence, use of over-the-counter medicines or dietary supplements, or contradictions in counselling.
conclusionPatient involvement is essential when identifying clinical DRPs. Indeed, poor therapy control, nonoptimal drug use, intentional or unintentional nonadherence might otherwise be missed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.